Economic considerations of Alzheimer's disease and related disorders.
Economic analyses of geriatric syndromes are seldom performed. However, demographic and epidemiological imperatives have led to significant interest in the evaluation of AD-related costs. Over 300 papers devoted to economic considerations of Alzheimer's disease have been published in peer-reviewed journals, within the last five years. In these papers, the chosen perspective (costs to society or to specific payers) is important. Analytical methods are still evolving and remain complex. Unresolved methodological issues will need to be addressed to further our understanding of long-term economic consequences. At present, it is clear that diagnostic and drug costs are low compared to the major cost of institutionalization. Thus, directing efforts at early diagnosis and delaying nursing home placement are two key cost-containment interventions. In this respect, the need to support informal care should not be underestimated.
Michel
J P
JP
Department of Geriatrics, Geneva University Hospitals, Switzerland. jean-pierre.michel@hcuge.ch
Zekry
D
D
Mulligan
R
R
Giacobini
E
E
Gold
G
G
D000368:Aged; D000544:Alzheimer Disease / Q000191:economics* / Q000628:therapy; D003365:Costs and Cost Analysis; D003704:Dementia / Q000191:economics* / Q000628:therapy; D017048:Health Care Costs; D006801:Humans; D012959:Socioeconomic Factors